Control of moderate-to-severe asthma with randomized ciclesonide doses of 160, 320 and 640 μg/day

about

Control of moderate-to-severe asthma with randomized ciclesonide doses of 160, 320 and 640 μg/day

Item

http://www.wikidata.org/entity/Q37698922

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 07 March 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Control of moderate-to-severe ...... ses of 160, 320 and 640 μg/day

@en

Control of moderate-to-severe ...... es of 160, 320 and 640 μg/day.

@nl

type

Item

label

Control of moderate-to-severe ...... ses of 160, 320 and 640 μg/day

@en

Control of moderate-to-severe ...... es of 160, 320 and 640 μg/day.

@nl

prefLabel

Control of moderate-to-severe ...... ses of 160, 320 and 640 μg/day

@en

Control of moderate-to-severe ...... es of 160, 320 and 640 μg/day.

@nl

P1476

Control of moderate-to-severe ...... ses of 160, 320 and 640 μg/day

@en

P2093

Henrik Andersson

http://www.w3.org/2001/XMLSchema#string

Niyati Prasad

http://www.w3.org/2001/XMLSchema#string

Søren E Pedersen

http://www.w3.org/2001/XMLSchema#string

Udo-Michael Goehring

http://www.w3.org/2001/XMLSchema#string

P2860

Switching from systemic steroids to ciclesonide restores the hypothalamic pituitary-adrenal axis.

Efficacy of low and high dose inhaled corticosteroid in smokers versus non-smokers with mild asthma.

The dose-response characteristics of inhaled corticosteroids when used to treat asthma: an overview of Cochrane systematic reviews.

From inhaler to lung: clinical implications of the formulations of ciclesonide and other inhaled corticosteroids.

Efficacy and safety of high-dose ciclesonide for the treatment of severe asthma.

Efficacy and safety of ciclesonide in patients with severe asthma: a 12-week, double-blind, randomized, parallel-group study with long-term (1-year) follow-up.

Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study.

Airway and systemic effects of hydrofluoroalkane formulations of high-dose ciclesonide and fluticasone in moderate persistent asthma.

Increasing doses of inhaled corticosteroids compared to adding long-acting inhaled beta2-agonists in achieving asthma control.

Ciclesonide, a novel inhaled steroid, does not affect hypothalamic-pituitary-adrenal axis function in patients with moderate-to-severe persistent asthma.

P304

35-46

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/JAA.S111712

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Dirkje Postma

P577

2017-03-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28331346

http://www.w3.org/2001/XMLSchema#string

P921

asthma

P932

5349703

http://www.w3.org/2001/XMLSchema#string